Plasmodium Falciparum Malaria Clinical Trials
90 clinical trials for Plasmodium Falciparum Malaria across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT) — RECRUITING
- MAL RISK II: Risk of complications in outpatient treatment of imported Plasmodium falciparum malaria – an observational study in TropNet — RECRUITING
- Mass Vaccine and Drug Administration, Bangladesh — RECRUITING · PHASE4
- Determinants of semi-immunity and disease tolerance in malaria — RECRUITING
- A study to assess the new malaria vaccine RH5.1/AS01 — COMPLETED · PHASE2
- Controlled Human Malaria Infection model for evaluation of transmission-blocking interventions – Study 1 — TERMINATED · PHASE2
- Evaluation of Interference and Synergy of Anti-Circumsporozoite Antibodies on GA2-induced Immunity — NOT_YET_RECRUITING · PHASE2
- R21/MM Dosing, Presentations, and Preservatives — NOT_YET_RECRUITING · PHASE4
- Persistent Plasmodium spp. infection — NOT_YET_RECRUITING
- Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand — COMPLETED · NA
- Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic — WITHDRAWN · NA
- Sleep in Malaria — OTHER
- Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant — ACTIVE_NOT_RECRUITING · PHASE1
- Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria — TERMINATED · PHASE2
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs. — COMPLETED · PHASE3
- Haemolysis after antimalarial treatment with artemisinins and other antimalarial drugs — OTHER
- Mass Screening and Treatment for Reduction of Falciparum Malaria — COMPLETED · NA
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia) — COMPLETED · PHASE3
- Additional Screening With Sensitives RDTs and Malaria — COMPLETED · PHASE3
- Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites. — COMPLETED · PHASE1
- Safety and protective efficacy of a simplified Plasmodium falciparum sporozoite chemoprophylaxis Vaccine (PfSPZ-CVac) regimen in healthy malaria-naïve adults in Germany — OTHER
- Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia — COMPLETED
- Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine — COMPLETED · PHASE2
- Human Immunity to MSP-1 in Western Kenya — COMPLETED
- Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria — COMPLETED · PHASE2
- Malarial Immunity in Pregnant Cameroonian Women — COMPLETED
- Drug Combinations of Atovaquone-Proguanil (AP) With ACT — OTHER · PHASE4
- Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic — COMPLETED · PHASE4
- Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria — COMPLETED · PHASE1
- DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria — COMPLETED · PHASE1
- Targeted Chemo-elimination (TCE) of Malaria — COMPLETED · NA
- SJ733 Induced Blood Stage Malaria Challenge Study — COMPLETED · PHASE1
- Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos — TERMINATED · PHASE1
- Time to Infection With Malaria Parasites — COMPLETED
- Malaria Transmission and Immunity in Highland Kenya — COMPLETED
- Malaria Prevalence in Children — COMPLETED
- Fetal Immunity to Falciparum Malaria — COMPLETED
- Plasmodium Resistance in A. Gambiae — COMPLETED
- SP Resistance and Falciparum Malaria Transmission — WITHDRAWN · PHASE3
- CS DNA MVA Trial in Mampong, Ghana — WITHDRAWN · PHASE1
- Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in Zanzibar — COMPLETED · PHASE4
- Efficacy of Artesunate + Amodiaquine Versus Artemether-lumefantrine for Falciparum Malaria in Zanzibar, 2005 — COMPLETED · PHASE4
- Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar — COMPLETED · PHASE4
- Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America — COMPLETED · PHASE1
- Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America — COMPLETED · PHASE1
- Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali — COMPLETED · PHASE2
- Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites — OTHER · PHASE2
- Malaria in Early Life Study — COMPLETED · NA
- Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine — WITHDRAWN · PHASE1
- Artemisinin-resistant Malaria in Cambodia — COMPLETED
Refine this search